Genesis Therapeutics is a pioneering company transforming the landscape of drug discovery through the integration of advanced machine learning, computational chemistry, and biology. Established on groundbreaking molecular machine learning research, Genesis has positioned itself as an industry leader with its innovative AI platform, GEMS (Genesis Exploration of Molecular Space), which significantly enhances the efficiency of discovering novel small molecule drugs. The company boasts a robust internal pipeline that focuses on high-value and challenging drug discovery areas. With over $300 million in funding raised from top-tier investors and collaborations with major pharmaceutical firms, Genesis Therapeutics is committed to scientific innovation and fostering an inclusive workplace, all while headquartered in Burlingame, CA, and operating a fully integrated laboratory in San Diego.